Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for MolPort-001-788-303

    Client Email Product

    MolPort-001-788-303

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    7
    US DMFs Filed

    US DMFs Filed

    4
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    2
    API REF. PRICE (USD / KG)
    3

    API Market Place

    12
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    16
    Europe

    Europe

    48
    Canada

    Canada

    25
    Australia

    Australia

    2
    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    7
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    101
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    4

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    18
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    Full View ScreenFull Screen View
    FDA Confirms Paragraph IV Patent Litigation for Lactic Acid, Citric Acid and Potassium Bitartrate
    FDA Confirms Paragraph IV Patent Litigation for Lactic Acid, Citric Acid and Potassium Bitartrate

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-lactic-acid-citric-acid-and-potassium-bitartrate-85917.pdf

    FDA
    25 Apr 2023
    Share Share
    Evofem Biosciences receives US patent covering Phexxi composition of matter
    Evofem Biosciences receives US patent covering Phexxi composition of matter

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153448&sid=2

    PHARMABIZ
    26 Sep 2022
    Share Share
    Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide
    Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

    https://www.prnewswire.com/news-releases/large-commercial-payer-adds-phexxi-to-formulary-for-standard-plans-nationwide-301626008.html

    PRNEWSWIRE
    16 Sep 2022
    Share Share
    Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®
    Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

    https://evofem.investorroom.com/2022-05-10-Evofem-Biosciences-to-Decrease-Cost-of-Goods-45-Percent-Through-New-Partnership-with-Bora-Pharmaceutical-Services-for-the-Commercial-Manufacturing-of-Phexxi-R

    PRESS RELEASE
    10 May 2022
    Share Share
    Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi
    Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

    http://www.pharmafile.com/news/635113/evofem-s-phase-iii-trial-reveals-fewer-utis-women-using-phexxi

    PHARMAFILE
    09 May 2022
    Share Share
    Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021
    Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021

    https://www.prnewswire.com/news-releases/evofem-biosciences-announces-record-net-sales-and-phexxi-prescriptions-in-q4-2021-301463762.html

    PRNEWSWIRE
    19 Jan 2022
    Share Share
    Formulation of Aqueous Core Poly(lactic acid) Microcapsules
    Formulation of Aqueous Core Poly(lactic acid) Microcapsules

    https://rodpub.com/email/cp/Whitepapers/Adare/4/Adare_Whitepaper.html

    RODPUB
    08 Dec 2021
    Share Share
    "House Rules" Delivers Strong Initial Results and Drives Phexxi Growth

    https://www.prnewswire.com/news-releases/house-rules-delivers-strong-initial-results-and-drives-phexxi-growth-301404476.html

    PRNEWSWIRE
    20 Oct 2021
    Share Share
    Rising Demand For Lactic Acid From Cosmetics And Pharmaceutical Industry
    Rising Demand For Lactic Acid From Cosmetics And Pharmaceutical Industry

    https://www.prnewswire.com/news-releases/rising-demand-for-lactic-acid-from-cosmetics-and-pharmaceutical-industry-to-drive-robust-revenue-growth-of-lactic-acid-market-reports-and-data-301388974.html

    PRNEWSWIRE
    30 Sep 2021
    Share Share
    3D-Printable Biomaterial Takes Shape for Tissue Scaffolds
    3D-Printable Biomaterial Takes Shape for Tissue Scaffolds

    https://www.mddionline.com/3d-printing/3d-printable-biomaterial-takes-shape-tissue-scaffolds

    Katie Pfaff MDDIONLINE
    20 Aug 2021
    Share Share
    Ilya’s Pharma to Present ILP100 Accelerated Wound Healing Gene Therapy
    Ilya’s Pharma to Present ILP100 Accelerated Wound Healing Gene Therapy

    https://news.cision.com/let-em-know-ab/r/ilya-s-pharma-receives-approval-from-swedish-regulators-to-initiate-phase-ii-clinical-study-of-ilp10,c3372906

    CISION
    23 Jun 2021
    Share Share
    Formulation of Aqueous Core Poly(lactic acid) Microcapsules
    Formulation of Aqueous Core Poly(lactic acid) Microcapsules

    https://www.contractpharma.com/csd/profile/adare-pharma-solutions/view_formulation-of-aqueous-core-polylactic-acid-microcapsules/?widget=listSection

    CONTRACTPHARMA
    14 Jun 2021
    Share Share
    Evofem Announces Launch of Phexx, First Non-Hormonal Contraceptive Vaginal Gel
    Evofem Announces Launch of Phexx, First Non-Hormonal Contraceptive Vaginal Gel

    https://www.prnewswire.com/news-releases/evofem-biosciences-announces-us-commercial-launch-of-phexxi-lactic-acid-citric-acid-and-potassium-bitartrate-the-first-and-only-non-hormonal-on-demand-prescription-contraceptive-vaginal-gel-301124288.html

    PRNEWSWIRE
    10 Sep 2020
    Share Share
    Evofem Announces Launch of Phexx,First Non-Hormonal Contraceptive Vaginal Gel
    Evofem Announces Launch of Phexx,First Non-Hormonal Contraceptive Vaginal Gel

    https://www.prnewswire.com/news-releases/evofem-biosciences-announces-us-commercial-launch-of-phexxi-lactic-acid-citric-acid-and-potassium-bitartrate-the-first-and-only-non-hormonal-on-demand-prescription-contraceptive-vaginal-gel-301124288.html

    PRNEWSWIRE
    08 Sep 2020
    Share Share
    U.S. FDA Approves Evofem Biosciences' Phexxi™
    U.S. FDA Approves Evofem Biosciences' Phexxi™

    https://www.prnewswire.com/news-releases/us-fda-approves-evofem-biosciences-phexxi-lactic-acid-citric-acid-and-potassium-bitartrate-the-first-and-only-non-hormonal-prescription-gel-for-the-prevention-of-pregnancy-301064469.html

    PRNEWSWIRE
    22 May 2020
    Share Share
    Enforcement Report - Week of March 22, 2017
    Enforcement Report - Week of March 22, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf

    FDA
    22 Mar 2017
    Share Share
    Lactic Acid Market Worth $3.82Bn & Polylactic Acid Market Worth $5.16Bn by 2020
    Lactic Acid Market Worth $3.82Bn & Polylactic Acid Market Worth $5.16Bn by 2020

    http://www.prnewswire.com/news-releases/lactic-acid-market-worth-382-billion-usd--polylactic-acid-market-worth-516-billion-usd-by-2020-560430031.html

    PR NEWS WIRE
    03 Dec 2015
    Share Share
    Dutch firm Corbion buys lactic acid business of Malladi Specialties
    Dutch firm Corbion buys lactic acid business of Malladi Specialties

    https://www.business-standard.com/content/b2b-chemicals/dutch-firm-corbion-buys-lactic-acid-business-of-malladi-specialties-115092300252_1.html

    Rakesh Rao BUSINESS-STANDARD
    23 Sep 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search